Vivani Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-26.6M | $-23.5M | $-25.7M | $-13.9M | $-12.8M | $-14.9M | $-33.6M | $-35.1M |
| Depreciation & Amortization | $424.0K | $400.0K | $357.0K | $381.0K | $345.0K | $164.0K | $397.0K | $435.0K |
| Depreciation | $400.0K | $400.0K | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.5M | $1.6M | $1.9M | $1.3M | $1.7M | $421.0K | $2.9M | $3.6M |
| Net Cash from Operating Activities | $-24.3M | $-20.8M | $-23.7M | $-18.8M | $-11.0M | $-16.8M | $-27.6M | $-29.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.2M | $556.0K | $887.0K | $338.0K | $572.0K | $330.0K | $493.0K | $163.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.2M | $-556.0K | $-887.0K | $-338.0K | $-572.0K | $68.0K | $-493.0K | $-163.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $23.3M | $19.1M | $133.0K | $63.4M | $11.6M | $8.6M | $35.0M | $26.6M |
| Net Change in Cash | $-2.1M | $-2.3M | $-24.5M | $44.3M | $97.0K | $-8.2M | $6.9M | $-3.4M |
| Free Cash Flow | $-25.5M | $-21.3M | $-24.6M | $-19.1M | $-11.5M | $-17.2M | $-28.1M | $-30.0M |